Wolters Kluwer ranked as Leader in Nucleus Research Supply Chain Planning Technology Value Matrix
Karen Abramson, CEO of Wolters Kluwer Corporate Performance & ESG, said: ' Wolters Kluwer's repeated Leader rankings in the Nucleus Research SCP Technology Value Matrix demonstrate our commitment to excellence and innovation. Our AI-powered CCH Tagetik Intelligent Platform enables the digital transformation of the office of the CFO and enhances organizational visibility into supply chain, financial and operational data. We remain committed to product excellence and innovation, anticipating market trends and delivering solutions that meet the evolving needs of our customers.'
For 2025, Nucleus Research highlighted new CCH Tagetik capabilities including Ask AI, a super agent that harnesses agentic AI to enable the simplification of scenario planning, forecast analysis and user interaction through visual dashboards, graphs and reports AI-based predictive intelligence and extended planning solutions. In addition, the report highlights further AI-enabled enhancements including driver-based analysis that supports Supply Chain Leaders, CFOs and their peers to identify opportunities and optimize operational efficiencies, resulting in faster, more accurate and better-informed decisions.
Charles Brennan, Senior Analyst, Nucleus Research, said: ' Many businesses struggle to manage their vast amounts of data effectively. Organizations need a supply chain planning tool to analyze and integrate this data for better decision-making and cost reduction. Nucleus found that Wolters Kluwer's investments in AI and integrated business planning enable CCH Tagetik customers to manage complex data more effectively, enhance enterprise planning and achieve stronger returns on investment.'
Wolters Kluwer Corporate Performance & ESG (CP & ESG) division is the world's leading provider of integrated software solutions for EHS, ESG, Corporate Performance Management and Audit and Assurance. Through innovative technology and unique expertise, Wolters Kluwer CP & ESG enables business leaders to make informed, strategic decisions driving transformation, performance and risk management for a sustainable and resilient world.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2024 annual revenues of €5.9 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,600 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
CLEARWATER, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) ('Apyx Medical;' the 'Company'), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that management will participate in the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, in Boston, MA. Charlie Goodwin, the Company's President and Chief Executive Officer, and Matt Hill, the Company's Chief Financial Officer, will participate in a fireside chat on Tuesday, August 12, 2025, at 4:00pm ET and will hold one-on-one meetings with investors throughout the day. The fireside chat will be accessible via live webcast here, and a replay will be available on the Events section of Apyx Medical's Investor Relations website at About Apyx Medical Corporation: Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® and now the AYON Body Contouring System™ in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at Investor Relations Contact:Jeremy Feffer Managing Director LifeSci Advisors OP: 212-915-2568 jfeffer@
Yahoo
an hour ago
- Yahoo
Office Properties Income Trust Announces Second Quarter 2025 Results
NEWTON, Mass., July 30, 2025--(BUSINESS WIRE)--Office Properties Income Trust (Nasdaq: OPI) today announced its financial results for the quarter ended June 30, 2025, which can be found at the Quarterly Results section of OPI's website at A conference call discussing OPI's second quarter results will be held on Thursday, July 31, 2025 at 10:00 a.m. Eastern Time. The conference call may be accessed by dialing (877) 328-1172 or (412) 317-5418 (if calling from outside the United States and Canada); a pass code is not required. A replay will be available for one week by dialing (877) 344-7529; the replay pass code is 5996892. A live audio webcast of the conference call will also be available in a listen only mode on OPI's website, at The archived webcast will be available for replay on OPI's website after the call. The transcription, recording and retransmission in any way are strictly prohibited without the prior written consent of OPI. About Office Properties Income Trust: OPI is a national REIT focused on owning and leasing office properties to high credit quality tenants in markets throughout the United States. As of June 30, 2025, approximately 59% of OPI's revenues were from investment grade rated tenants. OPI owned 125 properties as of June 30, 2025, with approximately 17.3 million square feet located in 29 states and Washington, D.C. In 2024, OPI was named as an Energy Star® Partner of the Year for the seventh consecutive year. OPI is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with approximately $40 billion in assets under management as of June 30, 2025, and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. OPI is headquartered in Newton, MA. For more information, visit A Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the shareholder, Trustee or officer is personally liable for any act or obligation of the Trust. View source version on Contacts Kevin Barry, Senior Director, Investor Relations(617) 219-1410 Erro ao recuperar dados Faça login para acessar seu portfólio Erro ao recuperar dados Erro ao recuperar dados Erro ao recuperar dados Erro ao recuperar dados
Yahoo
an hour ago
- Yahoo
ISS, Glass Lewis sue Texas AG over state's newest anti-ESG law
This story was originally published on ESG Dive. To receive daily news and insights, subscribe to our free daily ESG Dive newsletter. Dive Brief: Glass Lewis & Co. and Institutional Shareholder Services filed a lawsuit against Texas Attorney General Ken Paxton last week over the state's most recent anti-ESG law. The proxy advisory firms alleged in a July 24 complaint that the law is unconstitutional, and are seeking a preliminary injunction to stop it from going into effect, according to court records. The proxy advisors are looking to prevent the implementation of Texas Senate Bill 2337, passed by the state legislature in its most recent session and signed by Paxton June 2. The law would require proxy advisors who advise companies headquartered, incorporated in or re-domesticating to Texas to make that advice solely on financial interests and publish a disclosure if ESG or diversity, equity and inclusion concerns play a role in the advice, according to an analysis by law firm Foley & Lardner LLP. Glass Lewis and ISS are seeking a preliminary injunction to prevent the law from taking effect on Sept. 1 and claim the law violates their First Amendment right to free association and the First Amendment's prohibition on viewpoint discrimination, according to the complaint. Dive Insight: ISS and Glass Lewis, the two largest proxy advisors in the U.S., respectively, also said — in addition to alleging the First amendment violations — that SB 2337 violates the Employee Retirement Income Security Act of 1974, the commerce clause and is 'unconstitutionally vague.' Under SB 2337, proxy advisors would be deemed to have considered non-financial factors if their advice is 'wholly or partly based on, or otherwise takes into account, one or more nonfinancial factors, including a commitment, initiative, policy, target, or subjective or value-based standard based on' ESG, DEI, sustainability or social credit metrics or membership or commitment to certain groups. Under the law, the advisory firm would have 24 hours to publish a disclosure statement that 'conspicuously states that the service is not being provided solely in the financial interest of the company's shareholders because it is based wholly or partly on one or more nonfinancial factors,' according to the bill text. Advisory firms would also be required to explain their rationale in depth. ISS said the bill is 'unlawful multiple times over' in a press release shared with ESG Dive. The firm said the law is based on a 'fundamental misunderstanding' of proxy advisories' role and incorrectly assumes that a proxy advisory giving 'different recommendations to two different institutional investor clients is a problem to be solved for.' 'Serving clients on their own terms is a core value proposition of ISS,' the firm said in the July 24 release. 'Further, complying with SB 2337's mandated warnings will force ISS to falsely state that ISS' advice to its clients 'subordinates the financial interests of shareholders.'' A Glass Lewis spokesperson similarly panned the law in an emailed statement to ESG Dive Friday and said Texas left the firm with 'no choice but to take swift legal action to seek to enjoin enforcement of the law before it takes effect.' 'Texas SB 2337 is an unprecedented and blatantly unconstitutional law that targets proxy advisors and their institutional investor clients,' the spokesperson said. 'It is unworkable and it exposes both our business and our clients to unwarranted legal and regulatory risk.' The firms list Paxton as a defendant in his official capacity. Paxton's office did not respond to a request for comment. Recommended Reading Federal court dismisses ExxonMobil lawsuit against activist shareholder Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
